Verma on Track to be Confirmed as CMS Administrator Next Week | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Verma on Track to be Confirmed as CMS Administrator Next Week

March 9, 2017
by Rajiv Leventhal
| Reprints

The Senate today has advanced the nomination of Seema Verma, President Trump’s pick to run the Centers for Medicare and Medicaid Services (CMS), to a final floor vote tentatively scheduled for Monday March 13.

Breaking filibuster, the Senate invoked cloture for the nomination of Verma, meaning there would be no debate to go along with the vote today. A majority vote was needed to advance her nomination to the final Senate floor, and that’s precisely what happened, as Verma passed 54-44. Now, the final vote in the Senate will take place on Monday March 13 at 5:30 EST. Barring a total shock, Verma will be the next CMS Administrator.

Verma, president, CEO and founder of SVC, Inc., a national health policy consulting company, first faced the Senate Committee on Finance in February for a lengthy hearing  in which she was sharply questioned by Sen. Ron Wyden (D-Ore.), mostly about keeping Americans insured and her past conflicts of interest in which he alleged that she “contracted directly with the state of Indiana while also contracting with at least five companies that provided hundreds of millions of dollars in services and products to the programs she was helping the state manage.”

In a much shorter procedure on March 2, in which Verma did not speak, Sen. Wyden, the Senate Committee on Finance ranking member, again brought up his issues with Verma, but the committee nonetheless passed Verma’s nomination by a vote of 13-12. Meanwhile, Committee Chairman Orrin Hatch (R-Utah) was overwhelmingly in favor of Verma’s nomination, calling her “a highly-qualified nominee,” praise for which he said “there’s [no one] who reasonably disputes that.”

Regarding health IT, Verma emphasized in her Senate hearing the need to reduce complexities of CMS rules and regulations, and also the need to put decisions in the hands of doctors and patients. Healthcare Informatics will update readers on this story as it continues to unfold in the coming days.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More



Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.